VIMALKA filed trademark application TM99192483 with the USPTO on May 19, 2025, seeking registration of the wordmark VIMALKA for pharmaceutical preparations and products for use in oncology diseases and disorders. The application falls under Nice Classification 005 (pharmaceuticals) and is filed as an Intent-to-Use application, meaning the applicant has a bona fide intention to use the mark in commerce but has not yet done so.

Pharmaceutical companies and drug manufacturers should note this trademark filing when conducting clearance searches for oncology-related pharmaceutical products. Third parties who believe this mark conflicts with existing trademarks may file an opposition during the published opposition period. This is an informational trademark record and creates no immediate compliance obligations.